
-
2014
Company Description
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
Biohaven is a privately-held biopharmaceutical company engaged in the identification and development of clinical stage compounds targeting orphan neurologic indications and other neurological pathways.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Company Website:
-
Company E-mail:
-
Company Address:
234 Church StreetNew Haven, CTUnited States -
CEO:
- Vlad Coric
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits